Tinnitus Measured by MEG and Synchronous Neural Interaction™ Test: Template Development
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01185990|
Recruitment Status : Unknown
Verified March 2011 by Orasi Medical, Inc..
Recruitment status was: Recruiting
First Posted : August 20, 2010
Last Update Posted : March 23, 2011
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||45 participants|
|Observational Model:||Case Control|
|Official Title:||Moderate to Severe Tinnitus as Measured by MEG and the Synchronous Neural Interaction™ Test: Template Development Study|
|Study Start Date :||August 2010|
|Estimated Primary Completion Date :||August 2011|
|Estimated Study Completion Date :||August 2011|
Subjects with chronic, moderate to severe unilateral tinnitus.
|Healthy control subjects|
- Correlated brain activity [ Time Frame: 1 day ]MEG scan data will be analyzed using standard frequency domain approaches and the Orasi SNI test for correlated, synchronous activity.
- Tinnitus Severity Ratings [ Time Frame: Up to 14 days ]The degree of tinnitus severity also will be evaluated using the Iowa Tinnitus Handicap Questionnaire (THQ), Tinnitus Handicap Inventory (THI) and a Visual Analog Scale (VAS) of Tinnitus Severity.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01185990
|United States, Minnesota|
|Noran Neurological Clinic||Recruiting|
|Minneapolis, Minnesota, United States, 55407|
|Contact: Ann Rechtzigel, BSN 612-708-5357 email@example.com|
|Principal Investigator: Richard E Golden, MD|
|Minneapolis, Minnesota, United States, 55435|
|Contact: Anne-Marie Tschida 952-922-7000 ext 4640 firstname.lastname@example.org|
|Principal Investigator: Tami Helmer, MD|
|Principal Investigator:||Richard E Golden, MD||Noran Neurological Clinic|
|Principal Investigator:||Tami Helmer, MD||Radiant Research|